Analyst Ratings For NASDAQ:IART – Integra Lifesciences (NASDAQ:IART)
Today, JPMorgan Chase raised its price target on NASDAQ:IART – Integra Lifesciences (NASDAQ:IART) to per share.
Some recent analyst ratings include
- 4/5/2018-BTIG Research initiated coverage with a Neutral rating.
- 3/1/2018-Jefferies Group Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:IART – Integra Lifesciences (NASDAQ:IART)
NASDAQ:IART – Integra Lifesciences (NASDAQ:IART) has insider ownership of 5.10% and institutional ownership of 79.47%.
- On 4/30/2018 Daniel L Reuvers, VP, sold 1,000 with an average share price of $62.04 per share and the total transaction amounting to $62,040.00.
- On 3/14/2018 Glenn Coleman, VP, sold 8,769 with an average share price of $56.10 per share and the total transaction amounting to $491,940.90.
- On 3/9/2018 Joseph Vinhais, VP, sold 6,800 with an average share price of $54.13 per share and the total transaction amounting to $368,084.00.
- On 3/8/2018 Richard E Caruso, Major Shareholder, sold 32,880 with an average share price of $53.68 per share and the total transaction amounting to $1,764,998.40.
- On 3/5/2018 Christian S Schade, Director, sold 15,658 with an average share price of $52.88 per share and the total transaction amounting to $827,995.04.
- On 2/26/2018 Keith Bradley, Director, sold 15,658 with an average share price of $55.00 per share and the total transaction amounting to $861,190.00.
- On 11/20/2017 Jeffrey Mosebrook, Insider, sold 160 with an average share price of $47.41 per share and the total transaction amounting to $7,585.60.
Recent Trading Activity for NASDAQ:IART – Integra Lifesciences (NASDAQ:IART)
Shares of NASDAQ:IART – Integra Lifesciences closed the previous trading session at 63.50 down -1.02 1.59% with 64.80000305175781 shares trading hands.